Literature DB >> 21715028

Asymmetry of GPCR oligomers supports their functional relevance.

Pascal Maurice1, Maud Kamal, Ralf Jockers.   

Abstract

G protein-coupled receptors (GPCRs) can exist as dimers or as larger oligomeric clusters that enable intercommunication between different receptor protomers within the same complex. This phenomenon is observed at three distinct levels: (i) at the level of ligand binding where the activation of one protomer can allosterically inhibit or facilitate ligand binding to the second protomer; (ii) at the level of ligand-induced conformational switches, which occur between transmembrane domains of the two protomers; and (iii) within GPCR-associated protein complexes, either directly at the level of GPCR-interacting proteins or at further downstream levels of the complex. Intercommunication at these different levels introduces asymmetry within GPCR dimers wherein each protomer fulfills its specific task. In this review, we discuss how the asymmetric behavior of GPCRs highlights the advantage of oligomeric receptor organization and supports the functional relevance of GPCR dimerization.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715028     DOI: 10.1016/j.tips.2011.05.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  40 in total

1.  Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.

Authors:  Chantevy Pou; Clotilde Mannoury la Cour; Leigh A Stoddart; Mark J Millan; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

2.  Communication over the network of binary switches regulates the activation of A2A adenosine receptor.

Authors:  Yoonji Lee; Sun Choi; Changbong Hyeon
Journal:  PLoS Comput Biol       Date:  2015-02-09       Impact factor: 4.475

3.  Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells.

Authors:  Katharine Herrick-Davis; Ellinor Grinde; Tara Lindsley; Milt Teitler; Filippo Mancia; Ann Cowan; Joseph E Mazurkiewicz
Journal:  Mol Pharmacol       Date:  2015-01-21       Impact factor: 4.436

Review 4.  Structure-function of the G protein-coupled receptor superfamily.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-11-08       Impact factor: 13.820

5.  Asymmetry of the rhodopsin dimer in complex with transducin.

Authors:  Beata Jastrzebska; Tivadar Orban; Marcin Golczak; Andreas Engel; Krzysztof Palczewski
Journal:  FASEB J       Date:  2013-01-09       Impact factor: 5.191

6.  Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling.

Authors:  Richard M van Rijn; Jessica H Harvey; Daniela I Brissett; Julia N DeFriel; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2012-10-24       Impact factor: 4.030

Review 7.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

8.  GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Authors:  Lionel Moulédous; Carine Froment; Stéphanie Dauvillier; Odile Burlet-Schiltz; Jean-Marie Zajac; Catherine Mollereau
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

9.  Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.

Authors:  Xavier Guitart; Gemma Navarro; Estefania Moreno; Hideaki Yano; Ning-Sheng Cai; Marta Sánchez-Soto; Sandeep Kumar-Barodia; Yamini T Naidu; Josefa Mallol; Antoni Cortés; Carme Lluís; Enric I Canela; Vicent Casadó; Peter J McCormick; Sergi Ferré
Journal:  Mol Pharmacol       Date:  2014-08-05       Impact factor: 4.436

Review 10.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.